In vivo receptor assay with multiple ligand concentrations:: An equilibrium approach

被引:30
作者
Holden, JE
Jivan, S
Ruth, TJ
Doudet, DJ
机构
[1] Univ Wisconsin, Dept Med Phys, Madison, WI 53706 USA
[2] Univ British Columbia, Div Neurol, Dept Med, Vancouver, BC V5Z 1M9, Canada
[3] Univ British Columbia, TRIUMF, Vancouver, BC V5Z 1M9, Canada
关键词
raclopride; MPTP treated monkeys; D-2; receptors;
D O I
10.1097/00004647-200209000-00011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The ligand-receptor binding potential determined by in vivo PET studies at high ligand-specific radioactivity reflects both the receptor density and ligand-receptor affinity. This ambiguity has been resolved by various methods based on the administration of multiple unlabeled ligand concentrations. The authors aimed to implement and refine an approach to multiple ligand concentration receptor assay that combined maximum simplicity and a minimum of assumptions and model dependence that would nonetheless reliably distinguish density from affinity effects. The approach uses administration by bulus followed by infusion to obtain a true equilibrium between bound ligand and the other components of the ligand concentration, and does not require measurements of ligand in blood plasma, Four approaches to the optimization of the desired density and affinity parameters from the measured equilibrium data were implemented and compared in the analysis of raelo-pride studies performed in both normal control and MPTP-lesioned nonhuman primates. The authors conclude that the method is simple enough for routine use and yet reliable enough to apply in ongoing studies of both chronic and acute drug effects in the dopamine system.
引用
收藏
页码:1132 / 1141
页数:12
相关论文
共 30 条
[1]   STRIATAL D2 RECEPTOR STATUS IN PATIENTS WITH PARKINSONS-DISEASE, STRIATONIGRAL DEGENERATION, AND PROGRESSIVE SUPRANUCLEAR PALSY, MEASURED WITH C-11 RACLOPRIDE AND POSITRON EMISSION TOMOGRAPHY [J].
BROOKS, DJ ;
IBANEZ, V ;
SAWLE, GV ;
PLAYFORD, ED ;
QUINN, N ;
MATHIAS, CJ ;
LEES, AJ ;
MARSDEN, CD ;
BANNISTER, R ;
FRACKOWIAK, RSJ .
ANNALS OF NEUROLOGY, 1992, 31 (02) :184-192
[2]   COMPARISON OF BOLUS AND INFUSION METHODS FOR RECEPTOR QUANTITATION - APPLICATION TO [F-18] CYCLOFOXY AND POSITRON EMISSION TOMOGRAPHY [J].
CARSON, RE ;
CHANNING, MA ;
BLASBERG, RG ;
DUNN, BB ;
COHEN, RM ;
RICE, KC ;
HERSCOVITCH, P .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1993, 13 (01) :24-42
[3]   Quantification of amphetamine-induced changes in [C-11]raclopride binding with continuous infusion [J].
Carson, RE ;
Breier, A ;
deBartolomeis, A ;
Saunders, RC ;
Su, TP ;
Schmall, B ;
Der, MG ;
Pickar, D ;
Eckelman, WC .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1997, 17 (04) :437-447
[4]  
Delforge J, 1996, J NUCL MED, V37, P118
[5]   Absolute quantification by positron emission tomography of the endogenous ligand [J].
Delforge, J ;
Bottlaender, M ;
Pappata, S ;
Loc'h, C ;
Syrota, A .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2001, 21 (05) :613-630
[6]   QUANTIFICATION OF BENZODIAZEPINE RECEPTORS IN HUMAN BRAIN USING PET, [C-11] FLUMAZENIL, AND A SINGLE-EXPERIMENT PROTOCOL [J].
DELFORGE, J ;
PAPPATA, S ;
MILLET, P ;
SAMSON, Y ;
BENDRIEM, B ;
JOBERT, A ;
CROUZEL, C ;
SYROTA, A .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1995, 15 (02) :284-300
[7]   Quantitation of extrastriatal D2 receptors using a very high-affinity ligand (FLB 457) and the multi-injection approach [J].
Delforge, J ;
Bottlaender, M ;
Loc'h, C ;
Guenther, I ;
Fuseau, C ;
Bendriem, B ;
Syrota, A ;
Mazière, B .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1999, 19 (05) :533-546
[8]  
Doudet DJ, 2000, SYNAPSE, V38, P105, DOI 10.1002/1098-2396(200011)38:2<105::AID-SYN1>3.0.CO
[9]  
2-S
[10]   RELATION BETWEEN BRAIN DOPAMINE LOSS AND D2 DOPAMINE RECEPTOR DENSITY IN MPTP MONKEYS [J].
FALARDEAU, P ;
BEDARD, PJ ;
DIPAOLO, T .
NEUROSCIENCE LETTERS, 1988, 86 (02) :225-229